Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

newswire.ca - Piramal Pharma Limited Announces Results for Q1 FY27
Piramal Pharma Limited Announces Results for Q1 FY27
CNW

MUMBAI, India, July 29, 2026 /CNW/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30…

thehindu.com - The Hindu Bureau - Gland Pharma gets U.S. FDA nod for Sugammadex injection
Gland Pharma gets U.S. FDA nod for Sugammadex injection
The Hindu

Shares of Gland Pharma were in the spotlight on Tuesday, rising more than 4%, after the Hyderabad-based generic injectable drugmaker got the U.S. Food and Drug Administration (FDA) approval for its abbreviated new drug application for Sugammadex…

thehindubusinessline.com - KS Badri Narayanan - Q1 Results 30th July Live: Bajaj Finance, M&M, Tata Steel, Gillette, Vedanta, Torrent Pharma, Hyundai Motor, IRFC, Swiggy, NSDL, Niva Bupa, Mankind Pharma, Mazagon Dock, Thermax, Ajanta Pharma, Nuvama Wealth to announce Q1 results, Adani Ports, Asian Paints, Colgate, Waaree, Dabur shares down; Eiche
Q1 Results 30th July Live: Bajaj Finance, M&M, Tata Steel, Gillette, Vedanta, Torrent Pharma, Hyundai Motor, IRFC, Swiggy, NSDL, Niva Bupa, Mankind Pharma, Mazagon Dock, Thermax, Ajanta Pharma, Nuvama Wealth to announce Q1 results, Adani Ports, Asian Paints, Colgate, Waaree, Dabur shares down; Eiche
BusinessLine

Q1 Results Today, 30th July 2026 Live Updates: Get real-time Q1 FY27 earnings updates, profit growth, revenue numbers and management outlook from Saven Technologies, Aarcon Facilities, Aarti Industries, Archean Chemical Industries, Anlon…

marketbeat.com - NewAmsterdam Pharma (NAMS) Projected to Announce Earnings on Wednesday
NewAmsterdam Pharma (NAMS) Projected to Announce Earnings on Wednesday
MarketBeat

NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) is projected to issue its Q2 2026 results before the market opens on Wednesday, August 5th. Analysts expect the company to post earnings of ($0.48) per share and revenue of $1.8770 million for the…

marketbeat.com - Royalty Pharma (RPRX) Projected to Release Earnings on Wednesday
Royalty Pharma (RPRX) Projected to Release Earnings on Wednesday
MarketBeat

Royalty Pharma (NASDAQ:RPRX - Get Free Report) is expected to be releasing its Q2 2026 results before the market opens on Wednesday, August 5th. Analysts expect the company to announce earnings of $1.27 per share and revenue of $758.9270 million…

rediff.com - Nandita Malik - Indian Stock Markets Rise: IT Sector, Foreign Funds Boost Sensex, Nifty
Indian Stock Markets Rise: IT Sector, Foreign Funds Boost Sensex, Nifty
Rediff.com

Indian stock markets, including the Sensex and Nifty, opened higher, buoyed by a robust rally in IT sector shares, substantial foreign fund inflows, and a favourable drop in crude oil prices, even as global markets reacted to a hawkish US Federal…

seekingalpha.com - SA Transcript Insights Editor - Adaptive outlines MRD separation plan while raising 2026 MRD revenue guidance to $268M-$278M (NASDAQ:ADPT)
Adaptive outlines MRD separation plan while raising 2026 MRD revenue guidance to $268M-$278M (NASDAQ:ADPT)
Seeking Alpha

Management is actively pursuing the separation, seeing the MRD business as the primary value driver. They describe the Immune Medicine business as a 'call option,' aim to clarify the preferred path by year-end, have retained Morgan Stanley, and…

globenewswire.com - Arcadis N.V. - Arcadis Q2 and Half Year 2026 Results: Strong momentum for the next phase of profitable growth. Strategic targets in place for 2027-2029
Arcadis Q2 and Half Year 2026 Results: Strong momentum for the next phase of profitable growth. Strategic targets in place for 2027-2029
GlobeNewswire

Press Release | Arcadis Half Year 2026 Results & 2027-2029 Strategy Strong momentum for the next phase of profitable growth: strategic targets in place for 2027-2029 Organic net revenue growth step up to 2.2% for Q2‘26, 1.5% for…

thehindu.com - Pti - Stock markets trade in positive territory led by IT firms, foreign fund inflows
Stock markets trade in positive territory led by IT firms, foreign fund inflows
The Hindu

Benchmark indices Sensex and Nifty traded in positive territory during early trade on Thursday (July 30, 2026) driven by a rally in IT stocks, foreign fund inflows and a drop in crude oil prices. The 30-share BSE Sensex advanced 75.71 points to…

seekingalpha.com - High Alpha Professor - Nvidia's $5 Billion SSI Bet Could Protect Its Post-LLM Lead (NASDAQ:NVDA)
Nvidia's $5 Billion SSI Bet Could Protect Its Post-LLM Lead (NASDAQ:NVDA)
Seeking Alpha

Nvidia Corporation invests $5B in Safe Superintelligence, Inc. to gain privileged access to frontier AI research and future workload insights. NVDA's strategic rationale centers on closing its research feedback loop, countering hyperscaler…

yahoo.com - Soumya Eswaran - ICON Public Limited Company (ICLR) Surges on Net Book-to-Bill Strength
ICON Public Limited Company (ICLR) Surges on Net Book-to-Bill Strength
Yahoo!

Harris Oakmark recently released its second-quarter 2026 investor letter for the 'Oakmark U.S. Concentrated Strategy'. A copy of the letter can be downloaded here. The strategy returned 9.21% (net) in the second quarter, lagging the Russell 1000…

ibtimes.co.in - IBT Business Desk - Sensex Opens Below 77,650 Points, Nifty Holds Above 24,249 Amid Mixed Trends
Sensex Opens Below 77,650 Points, Nifty Holds Above 24,249 Amid Mixed Trends
IBTimes India

Domestic equity benchmarks opened on a subdued note on Thursday amid mixed global cues, as gains in information technology and pharma stocks were offset by weakness in banking and realty shares. Sensex opened at 77,638.86, down 15.74 points or 0.02…

newswire.ca - Valitic Surpasses 2 Million Trusted Customers, Marking a Major Milestone in Its Consumer Wellness Growth
Valitic Surpasses 2 Million Trusted Customers, Marking a Major Milestone in Its Consumer Wellness Growth
CNW

The rapidly growing skincare brand continues to strengthen its position in the U.S. beauty market through innovation, quality, and customer trust. HERZLIYA, Israel and CALGARY, AB, July 29, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE:…

swissinfo.ch - swissinfo.ch - Brazil approves generic GLP-1 drug sold by Swiss firm Sandoz
Brazil approves generic GLP-1 drug sold by Swiss firm Sandoz
www.swissinfo.ch

According to the statement, the Brazilian medicines regulator Anvisa has authorised the product Owozy for the treatment of type 2 diabetes. The product is being developed by Adalvo and will be marketed by Sandoz in Brazil. The market launch is…

smh.com.au - Javier Blas - War and drought: Another critical oil waterway is about to close
War and drought: Another critical oil waterway is about to close
The Sydney Morning Herald

You have reached your maximum number of saved items. Remove items from your saved list to add more. With apologies to Oscar Wilde, to lose one critical waterway may be regarded as misfortune; to lose two looks like carelessness. Of course, we're…

Receive a Daily briefing on Pharma Industry News

Get Started